Necroptotic genes in cancer cellular response to radiation
癌细胞对辐射反应中的坏死性凋亡基因
基本信息
- 批准号:10089416
- 负责人:
- 金额:$ 44.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-13 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Antineoplastic AgentsApoptosisBiologicalCause of DeathCell DeathCellsCellular MembraneCessation of lifeClustered Regularly Interspaced Short Palindromic RepeatsComplexDataEventExposure toFoundationsGenesGeneticGenetic TranscriptionIn VitroInflammationIntrinsic factorIntuitionLaboratoriesLeadMalignant NeoplasmsMediatingMitochondriaMitochondrial ProteinsModelingMolecularMusNecrosisOrganOutcomePatientsPhosphotransferasesPlayProductionProtein KinaseProteinsPublic HealthPublicationsRIPK1 geneRIPK3 geneRadiationRadiation ToleranceRadiation therapyReactive Oxygen SpeciesReportingResistanceRoleRuptureSignal TransductionStressSwellingTNFRSF1A geneTechnologyTissuesToxinTransgenic MiceTraumaTreatment outcomeTumorigenicityWhole OrganismXenograft procedurebasecancer cellcancer radiation therapycancer therapycell growthcell injurychemotherapeutic agentefficacy evaluationgenome editingin vivoinhibitor/antagonistinsightmouse modelneoplastic cellnovelradiation responseresponsesmall molecule inhibitortumortumor growthtumorigenic
项目摘要
Necrosis has long been recognized as a major form of cell death after cellular exposure to
radiation. Necrosis is generally thought to be a passive form of cell death caused by exposure to
stress that leads to initial swelling and eventual rupturing of cellular membrane. Thus it is
traditionally considered to be an unregulated form of cell death, in contrast to apoptosis, where
a defined cascade of molecular events leads to programmed cell death. The discovery of
necroptosis, which involves the systematic activation of select molecular factors that leads to
active permeabilization of cellular membrane, indicates that necrosis could be actively
regulated, similar to apoptosis. However, despite a recent surge of studies on the molecular
signaling events involved in necroptosis, its role in cancer radiotherapy remains unclear.
In this project, we propose to examine in the counter-intuitive hypothesis that the necroptotic
factors play key roles in sustaining tumor growth and mediating tumor resistance to
radiotherapy. Our hypothesis is based on recent results in our laboratory that indicated genetic
deficiencies in necroptotic genes led to weakened tumorigenic abilities and increased radiation
sensitivities of cancer cells. We will use state-of-the-art genome editing technologies such as
CRISPR to examine the role of the necriptotic genes in tumor growth and tumor resistance to
radiotherapy (Aim 1). We will also conduct studies to unveil the mechanisms through which the
necroptotic factors promote tumor growth and tumor resistance to radiation (Aim 2). Finally, we
will evaluate the anti-tumor efficacy of the small molecule inhibitors of the necroptotic factors
alone or in combination with radiotherapy (Aim 3). Upon completion of the project, we hope to
obtain a clearer picture of the role of necroptotic factors in tumor growth and tumor response to
radiation therapy.
长期以来,坏死被认为是细胞暴露于环境中后细胞死亡的主要形式。
辐射坏死通常被认为是一种被动形式的细胞死亡所造成的暴露于
导致细胞膜最初膨胀并最终破裂的应力。因此
传统上被认为是一种不受调节的细胞死亡形式,与细胞凋亡相反,
一系列明确的分子事件导致程序性细胞死亡。的发现
坏死性凋亡,它涉及选择的分子因子的系统激活,导致
细胞膜的活性透化,表明坏死可能是积极的,
类似于凋亡。然而,尽管最近对分子生物学的研究
尽管参与坏死性凋亡的信号传导事件,其在癌症放射治疗中的作用仍不清楚。
在这个项目中,我们提出了一个反直觉的假设,即坏死性下垂,
因子在维持肿瘤生长和介导肿瘤抵抗中起关键作用。
放疗我们的假设是基于我们实验室的最新结果,
坏死性凋亡基因的缺陷导致肿瘤发生能力减弱和辐射增加
癌细胞的敏感性。我们将使用最先进的基因组编辑技术,
CRISPR检测了坏死基因在肿瘤生长和肿瘤耐药性中的作用。
放疗(目标1)。我们亦会进行研究,以揭示
坏死因子促进肿瘤生长和肿瘤对辐射的抵抗(目的2)。最后我们
将评估坏死性凋亡因子的小分子抑制剂的抗肿瘤功效
单独或与放射疗法组合(Aim 3)。项目完成后,我们希望
更清楚地了解坏死性凋亡因子在肿瘤生长和肿瘤对
放射治疗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fang Li其他文献
Fang Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fang Li', 18)}}的其他基金
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
靶向 ATM 以增强放射治疗和免疫治疗的全身效应
- 批准号:
10586034 - 财政年份:2021
- 资助金额:
$ 44.3万 - 项目类别:
Targeting apoptotic caspases to enhance cancer radiotherapy
靶向凋亡半胱天冬酶以增强癌症放射治疗
- 批准号:
10305613 - 财政年份:2017
- 资助金额:
$ 44.3万 - 项目类别:
Receptor recognition and cell entry of coronaviruses
冠状病毒的受体识别和细胞进入
- 批准号:
9174759 - 财政年份:2016
- 资助金额:
$ 44.3万 - 项目类别:
MOUSE HEPATITIS CORONAVIRUS RECEPTOR-BINDING DOMAIN
小鼠肝炎冠状病毒受体结合域
- 批准号:
8361713 - 财政年份:2011
- 资助金额:
$ 44.3万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Control of biological reaction mechanism originated from apoptosis of adipose tissue vasculature
脂肪组织脉管系统凋亡调控生物反应机制
- 批准号:
18H03543 - 财政年份:2018
- 资助金额:
$ 44.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Systems biological analysis of mitochondrial apoptosis synergies evoked by 2nd generation TRAIL receptor agonists and cardic glycosides
第二代 TRAIL 受体激动剂和强心苷引起的线粒体凋亡协同作用的系统生物学分析
- 批准号:
324476878 - 财政年份:2016
- 资助金额:
$ 44.3万 - 项目类别:
Research Units
Molecular Cell Biological Analysis of Nuclear Condensation in Apoptosis
细胞凋亡中核凝聚的分子细胞生物学分析
- 批准号:
20590203 - 财政年份:2008
- 资助金额:
$ 44.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular biological investigation for the regeneration of inner ear sensory cells by controlling freeradical and apoptosis
通过控制自由基和细胞凋亡实现内耳感觉细胞再生的分子生物学研究
- 批准号:
15390519 - 财政年份:2003
- 资助金额:
$ 44.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biological significance of apoptosis signals and survival signals on radiosensitivity.
凋亡信号和存活信号对放射敏感性的生物学意义。
- 批准号:
14570879 - 财政年份:2002
- 资助金额:
$ 44.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Biological Studies on Cellular Proliferation and Apoptosis Induced by H. pylori
幽门螺杆菌诱导细胞增殖和凋亡的分子生物学研究
- 批准号:
14570445 - 财政年份:2002
- 资助金额:
$ 44.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular biological and molecular genetic studies in apoptosis of retinal ganglion cells and retinal differentiation.
视网膜神经节细胞凋亡和视网膜分化的分子生物学和分子遗传学研究。
- 批准号:
13470368 - 财政年份:2001
- 资助金额:
$ 44.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular biological analysis for apoptosis induction and variation of cytoskeltons & adhesion molecules in malignant melanoma
恶性黑色素瘤细胞凋亡诱导及细胞骨架和粘附分子变化的分子生物学分析
- 批准号:
12670815 - 财政年份:2000
- 资助金额:
$ 44.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biological study for osteoporosis -Apoptosis related gene expression-
骨质疏松症生物学研究-细胞凋亡相关基因表达-
- 批准号:
12671428 - 财政年份:2000
- 资助金额:
$ 44.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Cell Biological Study on Neuronal Apoptosis in Cerebellar Graneul Cells
小脑粒细胞神经元凋亡的分子细胞生物学研究
- 批准号:
10480216 - 财政年份:1998
- 资助金额:
$ 44.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)